# A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation and Strength of Suzetrigine

> **NCT06336096** · PHASE1 · COMPLETED · sponsor: **Vertex Pharmaceuticals Incorporated** · enrollment: 48 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Suzetrigine
- **DRUG:** Suzetrigine

## Key facts

- **NCT ID:** NCT06336096
- **Lead sponsor:** Vertex Pharmaceuticals Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-28
- **Primary completion:** 2024-06-19
- **Final completion:** 2024-06-19
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2024-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06336096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06336096, "A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation and Strength of Suzetrigine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06336096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*